Picture of InVitae logo

NVTAQ — InVitae News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln

April 24 (Reuters) - Laboratory service provider Labcorp
 LH.N  said on Wednesday it will acquire Softbank-backed
 9434.T  Invitae Corp's  NVTAQ.PK  assets auctioned through a
voluntary bankruptcy protection process, a few months after the
genetic test maker filed for bankruptcy.    
    Labcorp will acquire all of the bankrupt firm's assets on a
going concern basis for $239 million in cash consideration and
other non-cash consideration, the companies said in separate
statements. 
    In February, Invitae filed for voluntary Chapter 11
protection in a U.S. bankruptcy court and said that it intended
to pursue a sale process. 
    Invitae's estimated assets were in the $500 million - $1
billion range, while its liabilities were in the $1 billion -
$10 billion range, according to the bankruptcy filing. 


 (Reporting by Chandni Shah in Bengaluru; Editing by Mrigank
Dhaniwala)
 ((Chandni.shah@thomsonreuters.com;))

Recent news on InVitae

See all news